Pacet Tablet

Introduction

Pacet Tablet 100 mg is an antiarrhythmic medication primarily used to treat and prevent a variety of serious heart rhythm disorders such as ventricular tachycardia and atrial fibrillation. It works by stabilizing the heart's electrical activity, making it particularly useful in managing life-threatening arrhythmias.

Uses

Amiodarone is commonly used to treat:

Ventricular fibrillation (VF).
Ventricular tachycardia (VT).
Atrial fibrillation (AF) with rapid ventricular response.
Supraventricular arrhythmias.

It is often prescribed when other medications are ineffective or not well tolerated.

Brand Name	Pacet
Type	Tablet
Weight	100 mg
Generic	Amiodarone Hydrochloride
Manufacturer	Beximco Pharmaceuticals Ltd.
Available in	English বাংলা

Mechanism of Action

Amiodarone works by blocking multiple ion channels, including potassium, sodium, and calcium channels, which alters the electrical signals in the heart. It prolongs the action potential and the refractory period of the cardiac cells, stabilizing the heart rhythm and reducing the likelihood of arrhythmias.

How Long Does It Take to Work?

Amiodarone has a delayed onset of action, with initial effects typically seen within a few hours when given intravenously. Oral administration may take several days to weeks to achieve full therapeutic levels due to its complex pharmacokinetics and long half-life.

Absorption

Amiodarone is absorbed slowly and variably after oral administration, with an average bioavailability of 30-50%. Food can increase the absorption and bioavailability of oral doses.

Route of Elimination

Amiodarone is primarily eliminated via the liver and biliary excretion, with minimal renal excretion. Its metabolites are excreted in feces. Only about 1% of the drug is excreted unchanged in the urine.

Dosage

Tablet: 200 mg 3 times daily for 1 week reduced to 200 mg twice daily or the minimum required to control arrhythmia. Amiodarone is usually given in several daily doses to minimize stomach upset which is seen more frequently with higher doses. For this same reason, it is also recommended that Amiodarone should be taken with meals.

Injection: The recommended starting dose is about 1000 mg over the first 24 hours of therapy, delivered by the following infusion regimen:

Initial Load: 150 mg per 100 mL (in D5W or Normal Saline) infused over 10 minutes
Followed by: 1 mg/min for 6 hours
Followed by: 0.5 mg/min thereafter

In the event of breakthrough episodes of VF or hemodynamically unstable VT: Repeat the Initial Load described above as needed (infused over 10 minutes). Increase the rate of maintenance infusion to achieve effective arrhythmia suppression.

Amiodarone dosing varies based on the condition being treated:

For ventricular arrhythmias: Initial oral loading dose of 800-1600 mg/day for 1-3 weeks, followed by a maintenance dose of 400-600 mg/day.
For atrial fibrillation: Initial oral loading dose of 600-800 mg/day for 1-3 weeks, followed by a maintenance dose of 200-400 mg/day.
IV administration: A loading dose of 150 mg over 10 minutes, followed by 1 mg/min for 6 hours, and then 0.5 mg/min for 18 hours or until a transition to oral therapy.

Dosages should be individualized based on clinical response and patient tolerability.

Administration

Amiodarone can be administered orally or intravenously. For oral use, tablets should be taken with food to enhance absorption. IV administration is used in emergency settings or when rapid action is needed.

Side Effects

Common side effects of Amiodarone include:

Hypotension (low blood pressure).
Bradycardia (slow heart rate).
Corneal microdeposits.
Photosensitivity and skin discoloration.
Thyroid dysfunction (hyperthyroidism or hypothyroidism).
Pulmonary toxicity (lung inflammation or fibrosis).

Serious but rare side effects include liver toxicity, severe arrhythmias, and vision problems.

Toxicity

Amiodarone can cause toxic effects, especially with long-term use, including pulmonary fibrosis, liver toxicity, and thyroid dysfunction. Regular monitoring of lung, liver, and thyroid function is recommended for patients on chronic Amiodarone therapy.

Precautions

Precautions include:

Close monitoring of liver, lung, and thyroid function due to potential toxicities.
Avoiding exposure to sunlight, as Amiodarone can cause photosensitivity and skin discoloration.
Caution in patients with preexisting lung or liver disease.

Interaction

Amiodarone has numerous drug interactions due to its effect on the metabolism of other drugs:

It increases the effects of anticoagulants like Warfarin, leading to increased bleeding risk.
It may raise serum levels of statins, increasing the risk of muscle toxicity.
It interacts with digoxin, beta-blockers, and calcium channel blockers, increasing the risk of bradycardia or heart block.

Disease Interaction

Amiodarone should be used with caution in patients with:

Lung disease or a history of pulmonary toxicity.
Thyroid disorders, as it can cause both hyperthyroidism and hypothyroidism.
Liver disease due to the risk of hepatic toxicity.

Drug Interaction

Amiodarone interacts with various drugs:

Increases the effect of Warfarin, leading to a higher bleeding risk.
Increases serum concentrations of Digoxin, leading to potential toxicity.
Interacts with other antiarrhythmics and beta-blockers, potentially leading to bradycardia or heart block.

Close monitoring and dose adjustments may be necessary.

Food Interactions

Grapefruit juice can significantly increase the plasma concentrations of Amiodarone, increasing the risk of toxicity. Patients should avoid consuming grapefruit or grapefruit juice while taking Amiodarone.

Pregnancy Use

Amiodarone is classified as pregnancy category D, meaning it can cause harm to the fetus. It should only be used during pregnancy if the potential benefits justify the risk. It has been associated with fetal hypothyroidism and other congenital abnormalities.

Lactation Use

Amiodarone is excreted in breast milk and can cause harm to a breastfeeding infant. Breastfeeding is not recommended during Amiodarone therapy.

Acute Overdose

In the event of an acute overdose, symptoms such as severe bradycardia, hypotension, or cardiogenic shock may occur. Supportive care and close monitoring are required in cases of overdose. Hemodialysis is not effective in removing Amiodarone from the bloodstream due to its large volume of distribution.

Contraindication

Amiodarone is contraindicated in patients with:

Severe sinus node dysfunction causing marked sinus bradycardia.
Second- or third-degree heart block without a pacemaker.
Severe liver disease or hypersensitivity to Amiodarone or its components.

Use Direction

Amiodarone should be used under strict medical supervision. Regular monitoring of cardiac, thyroid, liver, and pulmonary function is essential. Dosages should be individualized based on the patient’s condition and response to therapy.

Storage Conditions

Amiodarone should be stored at room temperature, away from moisture and light. Keep the medication in a tightly closed container and out of the reach of children.

Volume of Distribution

Amiodarone has a very large volume of distribution (approximately 60 L/kg) due to its lipophilic nature. It accumulates in tissues such as fat, liver, and lung tissue.

Half Life

Amiodarone has a very long half-life, ranging from 20 to 100 days, depending on individual metabolism and tissue accumulation. It may take weeks to months for the drug to be eliminated from the body after discontinuation.

Clearance

Amiodarone is cleared primarily through hepatic metabolism, with only minimal renal clearance. Its clearance rate is slow due to its long half-life and extensive tissue distribution.

See in details version Pacet Tablet 100 mg also Pacet Tablet 100 mg in bangla